InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Sunday, 05/10/2015 8:34:07 PM

Sunday, May 10, 2015 8:34:07 PM

Post# of 80868
KISS: Keep It Simple Stupid!


KISS is an acronym for "Keep it simple, stupid" as a design principle noted by the U.S. Navy in 1960.[1][2] The KISS principle states that most systems work best if they are kept simple rather than made complicated; therefore simplicity should be a key goal in design and unnecessary complexity should be avoided.



This is really what Musclepharm needs. I'm not gonna tell anybody whether they should vote or what to vote when it comes to Musclepharm's proxy....but it strikes me that Musclepharm needs to use that many pages to explain it's compensation practices and board proposals.

I misunderstood everything to begin with as it was so freakin complicated. I mean, why is it that a relatively small company like Musclepharm needs so much complexity?

The same with pledging of executives' stocks....I mean, that is a deal that ultimately will go wrong. Musclepharm's stock is not marginable whatsoever....The company is under SEC investigation and most of it's shareholders are actively trading small investors and non trading insiders that have been granted stocks....What exactly good should come out of using these stock are security for a loan?

When Musclepharm needs money, it needs to go to the business or investment bank to get a loan, where it tries to maintain a good credit history by paying on time and not overstretching.....or alternatively Musclepharm raises capital by issuing stocks to investors.

There is nothing complex about this....pledging own stocks for obtaining loans is plain stupid imo.

Also, spending so much on compensation and endorsements, that it is almost impossible ever to post any profit no matter how much you sell for....is making things more complex than necessary.

It comes down to running a lean mean money making machine....not any of this nonsense.